منابع مشابه
Methylphenidate Transdermal System in Attention-Deficit Hyperactivity Disorder in Adolescentsy
Attention-deficit hyperactivity disorder (ADHD) is characterized by inattention, hyperactivity, and impulsivity. Globally, ADHD affects approximately 5–10% of children and persists into adolescence in up to 85% of affected individuals. Psychostimulants, such as methylphenidate and amfetamine, are the mainstay of treatment in ADHD. A patch that delivers methylphenidate transdermally (methylpheni...
متن کاملEfficacy of a methylphenidate transdermal system versus t.i.d. methylphenidate in a laboratory setting.
OBJECTIVE To test the efficacy and tolerability of the methylphenidate transdermal formulation (MTS) against immediate-release methylphenidate (IR MPH) and placebo in a 12-hr analog classroom setting. METHOD A total of nine boys ages 6 to 9 years, medicated with MPH for ADHD, complete a within-subject, double-blind study. For the purpose of the study, the boys are administered a dose of 20 cm...
متن کاملTransdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Stimulant medication and behavioral treatments are evidence-based for children with attention-deficit/hyperactivity disorder, but the combination of the 2 treatments has been understudied. In this investigation, methylphenidate (MPH) was crossed with 2 levels of behavior modification (BMOD) in a summer treatment program. Twenty-seven children with attention-deficit/hyperactivity disorder, aged ...
متن کاملDoes switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
BACKGROUND To evaluate health-related quality of life (HRQL) and medication satisfaction after switching from a stable dose of oral extended-release methylphenidate (ER-MPH) to methylphenidate transdermal system (MTS) via a dose-transition schedule in children with attention-deficit/hyperactivity disorder (ADHD). METHODS In a 4-week, multisite, open-label study, 171 children (164 in the inten...
متن کاملThe Selegiline Transdermal System (Emsam)
212 P&T® • April 2008 • Vol. 33 No. 4 ABSTRACT Although monoamine oxidase inhib itors (MAOIs) at one time represented the mainstay of therapy for major depressive disorder (MDD), the risk of acute hypertensive reactions following the ingestion of tyramine-rich foods and the consequent need to restrict dietary tyramine represent a barrier to their use. In this article, we present an overview of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Primary Care Companion to The Journal of Clinical Psychiatry
سال: 2010
ISSN: 1555-211X
DOI: 10.4088/pcc.10m00996pur